Accrol Group Holdings plc has reported strong H1 FY24 results, with impressive growth in adjusted EBITDA and adjusted PBT. The company remains on track to meet expectations and has seen gains in market share. Furthermore, the private label segment of the UK tissue market continues to increase, and the sales of biodegradable wet wipes have been exceptionally strong. Accrol's outlook remains positive with expected further volume growth.
Accrol Group Holdings plc has reported strong performance in H1 FY24, with branded volumes rising by 45% and margins returning to pre-pandemic levels. The group is on track to deliver FY24 results in line with expectations and expects to outperform previous expectations for FY25.
Tom Fraine, Equity Analyst at Shore Capital, analyzes Accrol Group Holdings' acquisition of Severn Delta. He highlights the positive business potential and strategic growth opportunities for the company. The planned self-funded investment in a paper mill is expected to drive further margin increases. Accrol's strong performance, low capex requirements, and favorable market conditions position it for continued success.